TAS0612, a novel RSK, AKT, and S6K inhibitor, exhibits antitumor effects in preclinical tumor models

标题
TAS0612, a novel RSK, AKT, and S6K inhibitor, exhibits antitumor effects in preclinical tumor models
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume -, Issue -, Pages -
出版商
American Association for Cancer Research (AACR)
发表日期
2023-11-01
DOI
10.1158/1535-7163.mct-21-1037

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search